FROM:
Am J Clin Nutr 1998 (Dec); 68 (6 Suppl): 1347S–1353S
Anderson JW, Blake JE, Turner J, Smith BM
Metabolic Research Group,
VA Medical Center and University of Kentucky,
Lexington, USA.
jwandersmd@aol.com
For > 150 y, clinicians and investigators have observed that high
protein intakes accelerate the progression of renal disease and
that low protein intakes have beneficial effects. Some studies
suggest that the effects of soy-protein intake resemble those of
a low-protein diet. The Brenner hypothesis suggests that high
protein intakes by diabetic individuals create hyperfiltration
and glomerular hypertension eventuating in renal damage. On the
basis of the available evidence, we are proposing the soy-protein
hypothesis, which states that substituting soy protein for animal
protein in diabetes patients results in less hyperfiltration and
glomerular hypertension and, therefore, resultant protection from
diabetic nephropathy.
Furthermore, substituting soy protein for animal protein should
have therapeutic value in diabetic nephropathy with resultant
slowing of deterioration of renal function and decreasing
proteinuria. The preliminary results of the study of 8 type 2
diabetes patients with obesity, hypertension, and proteinuria are
reported. Under the conditions of the study, providing soy
protein as half of the daily protein intake had no distinct
effects on renal function or proteinuria in these subjects.
Soy-protein intake was associated with a significant reduction in
serum cholesterol and triacylglycerol concentrations. Further
studies are required to critically examine the effects of
soy-protein intake on the renal function of diabetes patients.